These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3233881)

  • 1. Behçet's disease and major histocompatibility complex class II antigens in Tunisians.
    Hamza M; Ayed K; Hamzaoui K; Bardi R
    Dis Markers; 1988; 6(4):263-7. PubMed ID: 3233881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Behçet's disease and class II and III antigens of the major histocompatibility complex].
    Hamza M; Ayed K; Bardi R; Gorgi Y; Meddeb N
    Rev Rhum Mal Osteoartic; 1990 Jan; 57(1):59-61. PubMed ID: 2320926
    [No Abstract]   [Full Text] [Related]  

  • 3. HLA class II (DR, DQ, DP) in patients with sarcoidosis: evidence of an increased frequency of DRw6.
    Odum N; Milman N; Jakobsen BK; Georgsen J; Svejgaard A
    Exp Clin Immunogenet; 1991; 8(4):227-32. PubMed ID: 1817566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genetic study of Behçet's disease in Taiwan Chinese.
    Chung YM; Tsai ST; Liao F; Liu JH
    Tissue Antigens; 1987 Aug; 30(2):68-72. PubMed ID: 3672493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class I and class II MHC polymorphisms in Mexican patients with Behçet's disease.
    Soto-Vega E; García-Muñoz R; Richaud-Patin Y; Zúñiga-Ramos J; Crispín JC; Díaz-Jouanen E; Flores-Suárez LF; Llorente L; Granados J
    Immunol Lett; 2004 May; 93(2-3):211-5. PubMed ID: 15158619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombination sites in the HLA class II region are haplotype dependent.
    Gregersen PK; Kao H; Nunez-Roldan A; Hurley CK; Karr RW; Silver J
    J Immunol; 1988 Aug; 141(4):1365-8. PubMed ID: 3135331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic heterogeneity in uveitis.
    Cuccia Belvedere M; Martinetti M; de Paoli F; Mazzacane D; Redaelli C; Tafi A; Morone G
    Dis Markers; 1986 Oct; 4(3):243-6. PubMed ID: 3452481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Behçet's disease and HLA antigens--an association with a new specificity recognized by a monoclonal antibody].
    Nakayama T
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):643-52. PubMed ID: 2416665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some specific human leukocyte antigen (HLA)-DR/DQ haplotypes are more important than individual HLA-DR and -DQ phenotypes for the development of mucocutaneous type of Behçet's disease and for disease shift from recurrent aphthous stomatitis to mucocutaneous type of Behçet's disease.
    Sun A; Hsieh RP; Chu CT; Wang JT; Liu BY; Chiang CP
    J Oral Pathol Med; 2001 Aug; 30(7):402-7. PubMed ID: 11488417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA and celiac disease in Argentina: involvement of the DQ subregion.
    Palavecino EA; Mota AH; Awad J; Derosa S; Herrera M; Chertkoff L; Satz L; Fainboim L
    Dis Markers; 1990; 8(1):5-10. PubMed ID: 2311351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association between Behçet's disease and major histocompatibility complex class II antigens in an ethnically diverse North American Caucasoid patient group.
    Moore SB; O'Duffy JD
    J Rheumatol; 1986 Aug; 13(4):771-3. PubMed ID: 3772926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of HLA-B and DR phenotypes to Behcet's syndrome, recurrent oral ulceration and the class of immune complexes.
    Lehner T; Welsh KI; Batchelor JR
    Immunology; 1982 Dec; 47(4):581-7. PubMed ID: 6958639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behçet's disease.
    Mizuki N; Ota M; Katsuyama Y; Yabuki K; Ando H; Goto K; Nakamura S; Bahram S; Ohno S; Inoko H
    Arthritis Rheum; 1999 Sep; 42(9):1961-6. PubMed ID: 10513813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and associations of HLA-DR and HLA-DQ antigens in a British Caucasoid panel.
    Awad J; Navarrete C; Festenstein H
    Tissue Antigens; 1987 Jan; 29(1):55-9. PubMed ID: 3473746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An HLA-D region restriction fragment associated with refractory Behçet's disease.
    Numaga J; Matsuki K; Mochizuki M; Minami M; Juji T
    Am J Ophthalmol; 1988 May; 105(5):528-33. PubMed ID: 2897165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HLA and narcolepsy. Apropos of 28 cases including 2 negative HLA-DR2].
    Confavreux C; Gebuhrer L; Betuel H; Freidel C; Bastuji H; Jouvet M; Aimard G; Devic M
    Rev Neurol (Paris); 1988; 144(5):327-31. PubMed ID: 3262232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DR and DQ antigens in Chinese patients with Behçet's disease.
    Sun A; Lin SC; Chu CT; Chiang CP
    J Oral Pathol Med; 1993 Feb; 22(2):60-3. PubMed ID: 8445544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA antigens in Behçet's disease with refractory ocular attacks.
    Matsuki K; Juji T; Tokunaga K; Mochizuki M; Hayashi K; Fujino Y; Numaga J; Yamashita H
    Tissue Antigens; 1987 Apr; 29(4):208-13. PubMed ID: 3617033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological aspects of Behçet's and Vogt-Koyanagi-Harada's diseases.
    Ohno S
    Trans Ophthalmol Soc U K (1962); 1981 Sep; 101 (Pt 3)(3):335-41. PubMed ID: 6820735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor gene polymorphisms in Tunisian patients with Behcet's disease.
    Kamoun M; Chelbi H; Houman MH; Lacheb J; Hamzaoui K
    Hum Immunol; 2007 Mar; 68(3):201-5. PubMed ID: 17349875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.